META vs. REGN
META (Meta Platforms, Inc.) and REGN (Regeneron Pharmaceuticals, Inc.) are both stocks. META operates in Internet Content & Information (Communication Services), while REGN operates in Biotechnology (Healthcare). Over the past 10 years, META returned 17.39%/yr vs 5.35%/yr for REGN. At a 0.29 correlation, their price movements are largely independent.
Performance
META vs. REGN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, META achieves a -14.03% return, which is significantly higher than REGN's -20.48% return. Over the past 10 years, META has outperformed REGN with an annualized return of 17.39%, while REGN has yielded a comparatively lower 5.35% annualized return.
META
- 1D
- -0.26%
- 1M
- -8.32%
- YTD
- -14.03%
- 6M
- -11.84%
- 1Y
- -16.71%
- 3Y*
- 28.18%
- 5Y*
- 11.52%
- 10Y*
- 17.39%
REGN
- 1D
- 0.11%
- 1M
- -14.00%
- YTD
- -20.48%
- 6M
- -17.20%
- 1Y
- 16.30%
- 3Y*
- -7.00%
- 5Y*
- 3.27%
- 10Y*
- 5.35%
META vs. REGN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
META Meta Platforms, Inc. | -14.03% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
REGN Regeneron Pharmaceuticals, Inc. | -20.48% | 8.96% | -18.90% | 21.73% | 14.25% | 30.72% | 28.66% | 0.53% | -0.65% | 2.42% |
Correlation
The correlation between META and REGN is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.29 |
The correlation between META and REGN shifts across timeframes, from 0.10 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
META:
$1.45T
REGN:
$65.93B
META:
$27.47
REGN:
$41.05
META:
20.64
REGN:
14.91
META:
6.78
REGN:
4.42
META:
5.97
REGN:
2.10
META:
$214.96B
REGN:
$14.92B
META:
$176.14B
REGN:
$12.61B
META:
$106.31B
REGN:
$5.74B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
META vs. REGN — Risk / Return Rank
META
REGN
META vs. REGN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Meta Platforms, Inc. (META) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| META | REGN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.06 | ||
| Sortino ratioReturn per unit of downside risk | -1.54 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.12 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.54 | 0.70 | -1.24 |
| Martin ratioReturn relative to average drawdown | -1.12 | 2.16 | -3.28 |
Loading charts...
Drawdowns
META vs. REGN - Drawdown Comparison
The maximum META drawdown since its inception was -76.74%, smaller than the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for META and REGN.
Loading charts...
Drawdown Indicators
| META | REGN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.74% | -91.81% | +15.07% |
Max Drawdown (1Y)Largest decline over 1 year | -33.30% | -25.85% | -7.45% |
Max Drawdown (3Y)Largest decline over 3 years | -34.15% | -59.69% | +25.54% |
Max Drawdown (5Y)Largest decline over 5 years | -76.74% | -59.69% | -17.05% |
Max Drawdown (10Y)Largest decline over 10 years | -76.74% | -59.69% | -17.05% |
Current DrawdownCurrent decline from peak | -28.06% | -48.64% | +20.58% |
Average DrawdownAverage peak-to-trough decline | -15.83% | -42.45% | +26.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.06% | 8.33% | +7.73% |
Volatility
META vs. REGN - Volatility Comparison
The current volatility for Meta Platforms, Inc. (META) is 10.17%, while Regeneron Pharmaceuticals, Inc. (REGN) has a volatility of 12.77%. This indicates that META experiences smaller price fluctuations and is considered to be less risky than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| META | REGN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.17% | 12.77% | -2.60% |
Volatility (6M)Calculated over the trailing 6-month period | 26.91% | 22.14% | +4.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.52% | 32.77% | +2.75% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.04% | 30.79% | +13.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.67% | 32.17% | +6.50% |
Dividends
META vs. REGN - Dividend Comparison
META's dividend yield for the trailing twelve months is around 0.37%, less than REGN's 0.59% yield.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
META Meta Platforms, Inc. | 0.37% | 0.32% | 0.34% |
REGN Regeneron Pharmaceuticals, Inc. | 0.59% | 0.46% | 0.00% |
Financials
META vs. REGN - Financials Comparison
This section allows you to compare key financial metrics between Meta Platforms, Inc. and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
META vs. REGN - Profitability Comparison
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
REGN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
REGN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
REGN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.
Frequently Asked Questions
META and REGN have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
REGN has higher volatility (12.77%) compared to META (10.17%). In terms of maximum drawdown, META dropped -76.74% vs REGN's -91.81%.
REGN currently has the higher Sharpe Ratio (0.55 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for META and REGN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer